Stocktwits on MSN

CELC Stock Clocks Best Day In About 2 Months On First FDA Approval For Cancer Drug

Gedatolisib, in-licensed from Pfizer in 2021, is Celcuity’s sole late-stage asset.
The Observer

FDA opens door for Uganda’s cancer drug

Developing a new cancer medicine is often measured in years rather than months. On July 14, Ugandan scientist Matthias ...
Science Daily

Scientists use microcellular drones to deliver lung cancer-killing drugs

Extracellular vesicles (EVs) loaded with customizable anti-cancer antisense oligonucleotides suppressed cancer growth. Lung cancer, specifically Non-Small Cell Lung Cancer (NSCLC)-the most common ...

Celcuity Inc. (CELC) Discusses FDA Approval of REVTORPYK for Advanced HR+/HER2- Breast Cancer and Commercial Launch Plans Transcript

Discusses FDA Approval of REVTORPYK for Advanced HR+/HER2- Breast Cancer and Commercial Launch Plans July 14, 2026 5:30 PM ...
News Medical

Patient-derived organoids: Transforming cancer research and personalized medicine

New review highlights how mini-organs model tumor environments, enhance drug testing, and pave the way for personalized cancer treatments. Study: Patient-derived organoids in precision cancer medicine ...